West Pharmaceutical Services Inc. logo

West Pharmaceutical Services Inc. (WST)

Market Closed
18 Jul, 20:00
NYSE NYSE
$
210. 89
-10.7
-4.83%
$
15.88B Market Cap
49.01 P/E Ratio
0.8% Div Yield
1,472,900 Volume
7.62 Eps
$ 221.59
Previous Close
Day Range
206.8 222.69
Year Range
187.43 352.33
Want to track WST and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 3 days

Summary

WST closed yesterday lower at $210.89, a decrease of 4.83% from Thursday's close, completing a monthly increase of 1.43% or $2.98. Over the past 12 months, WST stock lost -36.04%.
WST pays dividends to its shareholders, with the most recent payment made on May 07, 2025. The next announced payment will be in In 2 weeks on Aug 06, 2025 for a total of $0.21.
The last earnings report, released on Apr 23, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0.15%, based on the last three reports. The next scheduled earnings report is due on Jul 23, 2025.
West Pharmaceutical Services Inc. has completed 4 stock splits, with the recent split occurring on Sep 27, 2013.
The company's stock is traded on 8 different exchanges and in various currencies, with the primary listing on NYSE (USD).

WST Chart

WST Stock Builds on GLP-1 Growth, Annex 1 and Margins in Focus

WST Stock Builds on GLP-1 Growth, Annex 1 and Margins in Focus

West Pharmaceutical Services rides on GLP-1 demand and Annex 1 expansion, but margins face pressure from pricing and tariff headwinds.

Zacks | 3 weeks ago
West Pharmaceutical (WST) Upgraded to Buy: Here's What You Should Know

West Pharmaceutical (WST) Upgraded to Buy: Here's What You Should Know

West Pharmaceutical (WST) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Zacks | 2 months ago
Does West Pharmaceutical (WST) Have the Potential to Rally 31.09% as Wall Street Analysts Expect?

Does West Pharmaceutical (WST) Have the Potential to Rally 31.09% as Wall Street Analysts Expect?

The average of price targets set by Wall Street analysts indicates a potential upside of 31.1% in West Pharmaceutical (WST). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Zacks | 2 months ago

West Pharmaceutical Services Inc. (WST) FAQ

What is the stock price today?

The current price is $210.89.

On which exchange is it traded?

West Pharmaceutical Services Inc. is listed on NYSE.

What is its stock symbol?

The ticker symbol is WST.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.8%.

What is its market cap?

As of today, the market cap is 15.88B.

What is the earnings per share?

The EPS is 1.51.

When is the next earnings date?

The next earnings report will release on Jul 23, 2025.

Has West Pharmaceutical Services Inc. ever had a stock split?

West Pharmaceutical Services Inc. had 4 splits and the recent split was on Sep 27, 2013.

West Pharmaceutical Services Inc. Profile

Medical - Instruments & Supplies Industry
Healthcare Sector
Eric M. Green CEO
NYSE Exchange
955306105 Cusip
US Country
10,600 Employees
30 Apr 2025 Last Dividend
27 Sep 2013 Last Split
13 Jan 1978 IPO Date
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. It serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services, Inc. was incorporated in 1923 and is headquartered in Exton, Pennsylvania.

Contact Information

Address: 530 Herman O. West Drive
Phone: 610 594 2900